Calidi Biotherapeutics, Inc. Investment Income, Interest
Calidi Biotherapeutics, Inc. (CLDI) reported Investment Income, Interest of $1.09 million for the 3-month period ending 2022-09-30, per its 10-Q filed 2022-11-14.
Discontinued › Income Statement › Other Income
us-gaap:InvestmentIncomeInterest · last filed 2023-03-31
- Calidi Biotherapeutics, Inc. investment income, interest for the quarter ending 2022-09-30 was $1.09M.
- Calidi Biotherapeutics, Inc. investment income, interest for the quarter ending 2022-06-30 was $160.00K.
- Calidi Biotherapeutics, Inc. investment income, interest for the quarter ending 2022-03-31 was $16.50K.
- Calidi Biotherapeutics, Inc. investment income, interest for the quarter ending 2021-12-31 was $1.67K.
| Period end | Investment Income, Interest 3 month | Investment Income, Interest 6 month | Investment Income, Interest 9 month | Investment Income, Interest 12 month |
|---|---|---|---|---|
| 2022-09-30 | $1.09M 10-Q · filed 2022-11-14 | $1.25M derived: sum of 2 quarters · filed 2022-11-14 | $1.27M 10-Q · filed 2022-11-14 | $1.27M derived: sum of 4 quarters · filed 2023-03-31 |
| 2022-06-30 | $160.00K 10-Q · filed 2022-08-10 | $176.50K 10-Q · filed 2022-08-10 | $178.17K derived: sum of 3 quarters · filed 2023-03-31 | $178.17K derived: sum of 4 quarters · filed 2023-03-31 |
| 2022-03-31 | $16.50K 10-Q · filed 2022-05-11 | $18.17K derived: sum of 2 quarters · filed 2023-03-31 | $18.17K derived: sum of 3 quarters · filed 2023-03-31 | $18.17K derived: sum of 4 quarters · filed 2023-03-31 |
| 2021-12-31 | $1.67K derived: 10-K 9 month − 10-Q 6 month · filed 2023-03-31 | $1.67K derived: sum of 2 quarters · filed 2023-03-31 | $1.67K 10-K · filed 2023-03-31 | |
| 2021-09-30 | $0.00 10-Q · filed 2022-11-14 | $0.00 10-Q · filed 2022-11-14 | ||
| 2021-06-30 | $0.00 10-Q · filed 2022-08-10 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| VivoSim Labs, INC. (VIVS) | United States | $0.003B | |
| WINDTREE THERAPEUTICS INC /DE/ (WINT) | United States | $0.003B | -0.32 |
| CURIS INC (CRIS) | United States | $0.002B | -0.05 |
| Silexion Therapeutics Corp (SLXN) | $0.001B | ||
| PharmaCyte Biotech, Inc. (PMCB) | United States | $0.005B | |
| AIM ImmunoTech Inc. (AIM) | United States | $0.006B | |
| CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC. (CELZ) | United States | $0.006B | |
| CERO THERAPEUTICS HOLDINGS, INC. (CERO) | United States | $0.007B | |
| TScan Therapeutics, Inc. (TCRX) | United States | $0.008B | -1.23 |
| Senti Biosciences Holdings, Inc. (SNTI) | United States | $0.011B | -0.70 |